Discrimination of atrial and ventricular signals from a single cardiac lead

• US 5,776,072 A
• Filed: 12/28/1995
• Issued: 07/07/1998
• Est. Priority Date: 12/28/1995
• Status: Expired due to Term

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Carlson, Gerrard M., Warren, Jay A., Hsu, William
• Primary Examiner(s): Getzow, Scott M.
• Application Number:
  US08/579,872
• Time in Patent Office: 922 Days
• Field of Search: 128/702, 128/705, 128/708, 607/5, 607/9, 607/14, 607/122, 607/123
• US Class Current: 600/518
• CPC Class Codes: A61N 1/3622 comprising two or more electrodes co-operating with different heart regions

Abstract

A method and system for discriminating atrial and ventricular signal components from a single heart lead, and for using this information for identifying an arrhythmia condition as being atrial or ventricular in origin. The invention is effective in identifying P waves occurring in complex signal which includes relatively stronger R waves or other ventricular artifacts which mask the P waves. The contribution of the R wave signal to the complex signal is obtained by filtering, time windowing and transfer function estimation, then the R wave estimate is subtracted from the combined signal to leave the P wave. The ratio of P waves to R waves, P--P and R--R intervals, and their ratios to one another and to fixed values can be estimated, and used in a comparison to discriminate between atrial and ventricular arrhythmia, to thereby enable appropriate treatment.

Claims

1. A method of discriminating atrial signals in a heart from ventricular and combined channel heart signals developed by a single endocardial lead system for placement in a heart, comprising the steps of:

a) sensing ventricular channel signals from an electrode of the endocardial lead system positioned in a ventricle of the heart;

b) sensing combined channel signals from an electrode of the endocardial lead system positioned to receive signals from an atrium of the heart;

c) detecting R waves from the ventricular channel signals;

d) selecting time windows for the ventricular channel signals and combined channel signals based on occurrence of an R wave;

e) estimating a transfer function of the ventricular channel signal to the combined channel during the selected time windows as a measure of a contribution of the R wave to the combined channel signals; and

f) subtracting the estimated transfer function from the combined channel signals to obtain remaining signals, whereby the remaining signals are an approximation of the P waves.

2. The method of claim 1, wherein said step of estimating a transfer function comprises least mean square recursive approximation.

3. The method of claim 1, further including transforming the ventricular and combined channel signals by Z-domain transfer filters prior to performing said steps of estimating and subtracting, and converting recovered P wave signals to time domain.

4. The method of claim 1, further including the step of determining from the rates of the R waves and recovered P waves if an atrial or ventricular arrhythmia has occurred.

5. A method of distinguishing atrial and ventricular arrhythmias in an implantable device including a single endocardial lead system, comprising:

a) sensing ventricular channel signals from an electrode of the endocardial lead system positioned in a ventricle of a heart;

b) sensing combined channel signals from an electrode of said endocardial lead system positioned to receive signals from an atrium of the heart;

c) recovering P waves from the combined channel signals by detecting R waves from the ventricular channel signals, estimating a contribution of R waves to the combined channel signals, and subtracting the estimated contribution of R waves from the combined channel signals;

d) determining an R wave rate and if the R wave rate is above a threshold value indicating tachycardia;

e) comparing a relative frequency of R waves and P waves to determine if a tachyrhythmia condition is atrial or ventricular in origin.

6. The method of claim 5, wherein the step of comparing a relative frequency of R and P waves includes:

distinguishing AF as a condition where a P wave rate is greater than the R wave rate;

distinguishing between exercise and SVT with a one-to-one ratio as a condition where the P wave rate substantially equals the R wave rate; and

distinguishing between VT and VF as a condition where the R wave rate is greater than the P wave rate.

7. The method of claim 6 further including activating the implantable device to treat VT or VF as a response when a VT or VF condition has been detected.

8. A system for detection of heart arrhythmia, comprising:

a) a lead system for placement in a heart;

b) a ventricular channel subsystem for sensing ventricular signals from an electrode of the lead system which is positioned in a ventricle of the heart;

c) a combined channel subsystem for sensing combined channel signals from an electrode of the lead system which is positioned for receiving signals from an atrium of the heart;

d) an R wave detector operative to detect R waves from heart signals received by the lead system;

e) means for gating selected time windowed intervals of the ventricular channel and combined channel signals based on occurrence of an R wave;

f) means for estimating a transfer function of the ventricular channel signal to the combined channel signals during the selected time windowed intervals as a measure of a contribution of the R wave to the combined channel signals; and

g) means for subtracting the estimated transfer function from the combined channel signals, whereby remaining signals are an approximation of P waves.

9. The system according to claim 8, wherein the lead system is a single endocardial lead having a ventricular electrode positioned thereon for placement in the ventricle when the lead is in its use position, and an atrial electrode positioned thereon for placement in the atrium when the lead is in its use position, and wherein the ventricular channel subsystem includes a connection to the ventricular electrode and the combined channel subsystem includes a connection to the atrial electrode.

10. The system according to claim 8, wherein the lead system is a single endocardial lead having a tip electrode positioned thereon for placement in the ventricle when the lead is in its use position, an RV coil adjacent the tip area for placement in the ventricle, an SVC coil positioned thereon for placement adjacent the atrium, and wherein the ventricular channel subsystem includes a connection to the tip electrode and said combined channel subsystem includes a connection to the SVC electrode.

11. The system according to claim 10, wherein the ventricular channel subsystem includes connections to the tip electrode and the RV coil, and the combined channel subsystem includes connections to the SVC coil and the RV coil.

12. The system according to claim 10, wherein the system comprises an implantable device, the ventricular channel subsystem includes connections to the tip electrode and the RV coil, and the combined channel subsystem includes connections to the SVC coil and the can or housing of the implantable device.

13. The system according to claim 8, wherein the lead system is a single endocardial lead having a tip electrode positioned thereon for placement in the ventricle when the lead is in its use position, an RV coil adjacent the tip area for placement in the ventricle, an atrial electrode positioned thereon for placement in the atrium, and an SVC coil positioned thereon for placement adjacent the atrium, and wherein the ventricular channel subsystem includes connections to the tip electrode and the RV coil, and the combined channel subsystem includes connections to the atrial electrode and the SVC coil.

14. A system according to claim 13, wherein the endocardial lead has a curved portion therein at a position to mechanically bias the atrial electrode into contact with the wall of the atrium, when the lead is in its use position.

15. A system according to claim 13, wherein the system comprises an implantable device, the ventricular channel subsystem includes connections to the tip electrode and the RV coil, and the combined channel subsystem includes connections to the atrial electrode and a can or housing of the implantable device.

16. A system according to claim 15, wherein the endocardial lead has a curved portion, taking the form of a lateral protrusion along the endocardial lead, therein at a position to mechanically bias the atrial electrode into contact with the wall of the atrium, when the lead is in its use position.

17. The system according to claim 8, further including means for determining if an R wave rate is above a threshold value indicating tachycardia, and means for comparing a relative frequency of R waves and P waves to determine if a tachyrhythmia condition is atrial or ventricular in origin.

18. A method of distinguishing atrial and ventricular arrhythmias in an implantable device including a single endocardial lead system, comprising:

a) providing an endocardial lead system positioned in a ventricle of a heart and having a pair of ventricular electrodes respectively at and adjacent a distal end of the lead system for contact in the ventricle, at least one atrial electrode positioned on the lead system at a curved portion therein at a position to mechanically bias the at least one atrial electrode into contact with a wall of an atrium, when the lead system is in its use position;

b) sensing ventricular channel signals from the pair of ventricular electrodes of the endocardial lead system;

c) sensing combined channel signals from the at least one atrial electrode of the endocardial lead system positioned in the atrium of the heart;

d) detecting R waves from the ventricular channel signals, and P waves from the combined channel signals;

e) determining if an R wave rate is above a threshold value indicating tachycardia;

f) comparing the relative frequency of the R waves and the P waves to determine if a tachyrhythmia condition is atrial or ventricular in origin.

19. The method of claim 18, wherein the step of comparing the relative frequency of the R waves and the P waves includes:

distinguishing AF as a condition where a P wave rate is greater than the R wave rate;

distinguishing exercise and SVT with a one-to-one ratio as a condition where the P wave rate substantially equals the R wave rate; and

distinguishing VT and VF as a condition where the R wave rate is greater than the P wave rate.

20. The method of claim 19 further including activating the implantable device to treat VT or VF as a response when a VT or VF condition has been detected.